Quadria Capital-backed Maxivision Eye Hospitals has officially filed for an IPO through Sebi's confidential route, as confirmed by a newspaper advertisement on Friday. The eye-care chain had previously appointed ICICI Securities and IIFL Capital as bankers in July for an IPO that would include a mix of newly issued shares and stock sold by existing investors. According to Reuters, this confidential filing mechanism allows companies to submit draft IPO papers to the market regulator without public disclosure, keeping financial and operational details private while seeking regulatory approval.
Founded in 1996, Maxivision operates more than 90 centres across six states and competes with eye-care chains including Dr. Agarwal's Health Care, Centre for Sight and ASG Eye Hospitals. According to company data, the eye-care chain has established a significant presence in the Indian healthcare sector over its nearly three-decade operational history, positioning itself as a major player in the specialized eye-care segment.
India's eye-care market is projected to grow to $31.2 billion by 2033 from $12.8 billion in 2025, according to Grand View Research. This substantial growth trajectory presents significant opportunities for established players like Maxivision to expand their market presence and strengthen their competitive position in the evolving healthcare landscape. The company's strategic positioning in this growing market segment positions it well for potential growth and expansion opportunities.
